chrisvoncsefalvay/vaers-outcomes huggingface dataset:
antibody/antigen testing; received vaccine on Monday  then tested positive last night; This is a spontaneous report from a contactable pharmacist (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date in Dec2020 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient called about antibody/antigen testing.  She tested negative on Sunday (Dec2020), received vaccine on Monday (Dec2020) then tested positive last night (Dec2020). She wanted to know if she truly has Covid or if it positive due to the vaccination. She gets tested every three day because she works in a long-term care facility. Outcome of the event was unknown.   Information about batch/lot number has been requested.
Sx:  Vessicular erruption with subsequent cellulitis of RLe + inguinal LAB.  Tx:  ORAPRED 15 mg qd x sd;  AUGMENTIN 250 mg bid x 10d.
erythema 30 mm X 70 mm. Itchy. no fever, no respiratory problems.
Headache, chills, muscle aches and fever for about 28 hours. Highest fever recorded was 101.5 F
This spontaneous report as received from a 61-year-old male patient, who was also a pharmacist and refers to himself. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On an unknown date, the patient administered ZOSTAVAX (dose, lot#, expiration date and route of administration were not reported). The pharmacist stated that he did not wear gloves when he reconstituted the ZOSTAVAX. Sometimes after reconstituting, while he was trying to get the air out of the syringe, a small droplet formed at the end of the needle. Event though the droplet had no contact with his skin, it was possible that the droplet fell on the work surface. On 10-DEC-2015, pharmacist noticed the skin of outside edge of his left eye was itchy, not intense but was felt. He thought maybe he was contacting conjunctivitis, which did not develop. Another time, he felt a twinge at the same site of left eye (date unspecified). The patient stated that the night before the onset, he ate chili and was wondering if he somehow touched that area of his eye. Pharmacist stated all symptoms of the left eye resolved on approximately 14-DEC-2015. On 15-DEC-2015, he had itching on the left side of his lower ribs to the middle of back going around toward the front. He stated he had no rash, no papules, no shingles, only redness, which could have been from scratching. The patient mentioned he did yard work the day before and that could have been the cause. The outcome of itching on the left side of his lower ribs to the middle of back going around toward the front and redness was not reported. Causality assessment was not provided. Additional information has been requested.
Patient states he has an itchy rash on both arms and legs that started after receiving the vaccine. He had an appointment with his doctor but canceled because it was getting better with hydrocortisone cream. Patient says it is worse now and the itching keeps him up at night. He says he will follow up with his doctor tomorrow.
She got her vaccine, 9 days later on 11/11/22 she had crazy vision, eyes like they were going back into her head  This did not last long and was scary.  She was told to go sit down at work and went away.  A week later she had this again and that time she got confused and did not remember what day it was.  She went to the doctor about it, did not see anything wrong with her. On 1/7/23 she was feeling weird and listing at home, having problems with her face and her left side and her head felt weird.  She had a virus in December, and her eyes were acting crazy at that time.  Then in January she went to the ER on 1/7/23, and they thought that she was having TIA's.  She was kept and had an MRI of her brain and then said that everything looked fine, all vessels and arteries were fine, but had symptoms of stroke like.  She is scheduled to have a brain wave study on 3/20/23.  She did have an MRI on her cervical neck, not related to the vaccine.  Her blood pressure has increased, and has some pressure in her head since starting BP medicine, started in February of 2023.  She feels really bad with the BP.  She went to her PCP the next day and it was normal, and she continues to have fluctuations of her blood pressure, weakness in her left arm, strange feelings in her face.  She has had about 6 episodes of the cray vision and have gone and is hoping that these other symptoms will be going away, but none of the doctors have any idea what is going on.  She has been to the hospital 2 times due to BP issues.  Her heart was checked on the 2nd visit to the ER, all of her values were OK, and right now it is 160/83.  She is now taking Carvedilol 3.125 twice a day.   She just does not feel good and feels sometimes like she is not going to make it.
On day 8 post vaccine patient's injection site began itching and developed a large knot  and the inside of her mouth became "puffy"
DEVELOPED LEFT LOWER EXTREMITY WEAKENSS for 72 hours post vaccination. Loss of sensation in left foot continues.
The patient did not experience any side effects and no other AE occurred; The customer reported they have a patient who received PEDV AX HIB and ROT ATEQ after the products we improperly stored.; This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender.  No information regarding concurrent conditions, medical history or concomitant medications was provided.  On 08-APR-2021, the patient was administered 1 dose of improperly stored Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot 1684166 and expiration date 27-JUN-2021 and 1 improperly stored dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot T020615 and expiration date:13-MAR-2023 for prophylaxis (dose, dose number and vaccination schemes frequency were not reported). The involved vaccine underwent a temperature excursion of 51.4 degrees Fahrenheit for 30 minutes. No Data Logger was involved. No previous temperature excursions were reported.   At the time of the report no adverse event was reported.
bilateral burning hands and feet which has been constant and persistent.  Burning hand pain has resolved but burning foot pain has persisted
On that day February 3, I experienced excruciating pain in my right big toe joint which felt like burning sensations. That burning and pain sensation lasted up until roughly Saturday. February 5, 2022. On February 4 is when I did go to the doctor in relation to this flare up. Prescribed prednisone 2x20mg tabs daily (5 days) to help bring down the burning and inflammation. Because of the burning and inflammation, I was immobile for those 3 days because of the pain.
pt recv vax; had redness & swelling at inject site; 19jun95 had knot in neck; lt side red & swollen;
Patient was given an overdiluted 0.3mL dose. They received slightly less than 1cc of required dose. Patient waited 15 minutes in observation with no issue.
PAINFUL LYMPH NODES AT ARMPIT; ENLARGED LYMPH NODES AT ARMPIT; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced painful lymph nodes at armpit, and enlarged lymph nodes at armpit. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the painful lymph nodes at armpit and enlarged lymph nodes at armpit was not reported. This report was non-serious. This case, from the same reporter is linked to 20210943896 and 20210849152.
Patient developed tight feeling in throat, difficulty swallowing, diaphoretic, clammy skin and facial swelling around eyes.
Left hand weakness and tingling, dizziness, injection site throbbing 10 min post vax Observation, fluids, food Sxs largely resolved after 30 mins of close monitoring, returned to shift feeling a little lightheaded NKA
1st dose Dec2021, 2nd not yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 92-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 0.5 ml of first dose on 9th December 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 27-Oct-2022 Reporter's comment: The pharmacist stated that the patient had not yet gotten the second one (past the recommended 6 months). The reporter did not had any further information about the vaccine itself. Did not consent to follow-up. Additional supportive information: Till the time of reporting the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 61 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin; "Known allergies: Peanuts" (unspecified if ongoing), notes: Known allergies: Peanuts; "Known allergies: Shellfish" (unspecified if ongoing), notes: Known allergies: Shellfish. Concomitant medication(s) included: ADVIL [IBUPROFEN], start date: 01May2022; BENADRYL, start date: 02May2022. Past drug history included: Ceclor, reaction(s): "Known allergies: Ceclor", notes: Known allergies: Ceclor. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset May2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Negative, notes: Tested negative after taking Paxlovid days 6 thru 9; (May2022) Negative, notes: Tested negative after taking Paxlovid days 6 thru 9; (May2022) Negative, notes: Tested negative after taking Paxlovid days 6 thru 9; (May2022) Negative, notes: Tested negative after taking Paxlovid days 6 thru 9; (May2022) Positive, notes: Now testing positive day 10. Therapeutic measures were taken as a result of covid-19, drug ineffective.  Additional information: Adverse event: Tested negative after taking Paxlovid days 6 thru 9. Now testing positive day 10. Device Date:16May2022  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture date of expiration) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture date of expiration) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. It was reported that vials had not undergone any temperature excursion. Total of 168 doses/vials were given for LOT 048C21A. No treatment medication were reported. Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received contains non significant information.
Received PRP-OMP & BPIG (IND drug) after being evaluated & found afeb. & in good health.  Infant was found apneic in his bed the next AM.
EMS found pt with BG of 30, may not have eaten in several days per family stating he's felt so ill; Brought to ED with multiorgan failure; experienced PEA arrest x 6 min; intubated; admitted to ICU; hematemesis, seizure, hypoglycemic; positive for COVID; treated hypoglycemia; gave ABX; vasopressors; pt's condition worsened; progressive acidosis and persistent shock despite aggressive measures; family made pt a DNR; removed life support and pt died in the hospital
Patient received Menactra on 9/5/07 and presented in my office with the following symptons on 9/6/07:  High fever, difficulty breathing, weakness, a fast heart beat, and dizziness, and felt sore. Vaccine received from program.
she is having diarrhea.; some stomach issues; sore arm; This is a spontaneous report from a contactable consumer or other non hcp.   A 52-years-old female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE), dose 2 via an unspecified route of administration on 09Feb2021 (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was stated she received the first dose of the vaccine on 19Jan2021 and the second dose 3 weeks later on 09Feb2021. She stated she did not have any side effects after either dose other than a sore arm on an unspecified date Feb2021. However today she is having diarrhea. She asked if this could still be related to the vaccine and how long she might experience this. The patient was vaccinated both doses of the Pfizer Covid19 vaccine. The first one on 19Jan and the second one on 09Feb. So, that is 3 weeks apart and I have zero side effects from both. The first time my arm hurt a little bit more than the second time. So, it has been 6 days since the patient had the second dose and today she was having some diarrhea and some stomach issues on 15Feb2021, the patient treatment received 2 Imodium. Would it be possible that it stated from the vaccine 6 days ago or not. Outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up (12MAY2021): Follow-up attempts completed. No further information expected
A spontaneous report has been received from VAERS concerning a 46 years old male patient. The patient's medical history included diverticulitis, irritable bowel syndrome, bipolar disorder, gall bladder remove and surgery. The patient's concurrent disease included pneumonia. On 09-Nov-2009, patient received FLUMIST (intranasal) and on an unknown date H1N1 (intranasal). It was reported that patient had pain in legs moving upward throughout body within two days also affected hand movement. Leg paralysis leading to hospitalization. From then on headaches body spasms, burning sensation in extremities. Extreme Pain, confusion, nausea, diarrhea, unconfirmed diagnosis of GBS treated with pain medication and intravenous immunoglobulin. The outcome of the event of Guillain-Barre syndrome was unknown. Reporter assessed the event of Guillain-Barre syndrome to be serious as hospitalization.
pt recv vax; tightness in chest, palpitations, lightheaded 1 hr p/ vax; dph , O2 adm; to hlth clinic;
Approximately 15 hours after the injection I experienced very sore arm, fever, chills, muscle aches, headache, sinus congestion, and loss of taste. All symptoms began to subside within 24 hours of occurrence except for sense of taste.
a sore left arm shoulder deltoid muscle; a sore left arm shoulder deltoid muscle; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (a sore left arm shoulder deltoid muscle) and INJECTION SITE PAIN (a sore left arm shoulder deltoid muscle) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011LT0A and 010M20A) for COVID-19 vaccination.     Medical history was not provided.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (a sore left arm shoulder deltoid muscle) and INJECTION SITE PAIN (a sore left arm shoulder deltoid muscle). At the time of the report, MYALGIA (a sore left arm shoulder deltoid muscle) and INJECTION SITE PAIN (a sore left arm shoulder deltoid muscle) outcome was unknown.            No concomitant medication were reported. No treatment information was reported.
Chills; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 20Apr2021 16:45 (Lot number: ER2613) at the age of 31 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, Administration time=04:45 PM, Lot number = ER2613, vaccine location=Right arm), administration date: 30Mar2021, when the patient was 31 years old, for Covid-19 Immunisation. The following information was reported: CHILLS (non-serious) with onset 21Apr2021 09:00, outcome "recovering", described as "Chills"; HEADACHE (non-serious) with onset 21Apr2021 09:00, outcome "recovering", described as "Headache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills.  Additional Information: The patient was not tested positive for COVID-19 prior vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The laboratory result included SARS-CoV-2 test was negative on 09Apr2021.  No follow-up attempts are possible. No further information is expected.
Three days after receiving the vaccine, my left cheek felt numb. It lasted over an hour and then went away.Two days later,once again, my left cheek felt numb (like Novocaine was wearing off); This is a spontaneous report from a contactable consumer (patient). A 70-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL9264), via an unspecified route of administration on arm left on 15Feb2021 11:00 AM (Age at Vaccination: 70 years) as dose 1, single for COVID-19 immunisation. Facility type vaccine  was reported as Public Health Clinic/Veterans Administration facility. The patient medical history was reported as none and had no known allergies. Covid prior vaccination and covid tested post vaccination was reported as no. If other vaccine in two or four weeks was reported as no. The patient Concomitant medications were not reported. On 18Feb2021 12:00 PM, Three days after receiving the vaccine, my left cheek felt numb and tingly. It lasted over an hour and then went away. Two days later, once again, my left cheek felt numb (like Novocaine was wearing off). Again it lasted about an hour and a half. I have never ever experienced this before receiving the vaccine. This morning it feels like it is starting again. My concern.do I receive the second vaccine??? The patient did not receive any treatment for the events. The outcome of the event was not resolved.  No Follow-up attempts are needed. No further information is expected.
Went to ER via ambulance, around 22:30 - 21:00 the baby was being held when he became yellow, pale and didn't respond appropriately for a couple of minutes. Patient had second episode while waiting for ambulance. For EMS and on arrival pt awake, alert in no apparent distress.
one hour after first dose of moderna vaccine developed nausea/vomiting and chills/rigors. Was taken to our urgent care center: vitals stable and within normal range, lab work wnl. No skin rash, airway or breathing difficulty, wheeze. Was given IV fluids, tylenol and zofran and then discharged home to recuperate.
SWOLLEN THROAT; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination.  No concomitant medications were reported. The batch number was not reported and has been requested. On 10-MAR-2021, the patient  experienced swollen throat. reporter report that after 4 days of vaccination suffering from throat swollen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of swollen throat was not reported. The reporter considered the causality between covid-19 vaccine ad26.cov2.s and swollen throat was related  .Company causality between covid-19 vaccine ad26.cov2.s and swollen throat was related . This report was non-serious.
suffered from gout; I am in considerable pain; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown) dose 2 via an unspecified route of administration on 23Aug2021 as dose 2, single for covid-19 immunization. The patient medical history was not reported. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN (E.C.). The patient stated, just got the second vaccine (Covid-19 Vaccine) two days ago and the second one Pfizer and suffered from gout and was in considerable pain on 23Aug2021. Wanted to know if the patient can take an Aspirin. Outcome of events was unknown.  The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.
2days p/vax pt devel rash, & was contained on top side of both arms.
Patient came to pharmacy with red quarter size spot at ZOSTAVAX administration site. No itching, no heat, no streaking. Called doctor's office and they said tell pt to watch it. When called the patient the red spot had gotten larger and advised her to call Dr. She saw Dr. they told her ice and BENADRYL.
Subsequently the pt developed a "frozen" left shoulder for 2-3 weeks. As of 10/23/00, the outcome of the event is resolved.
wheezy and short of breath but lung sounds are clear   1 MG/2ML nebulizer suspension, albuterol - DX Bronchial pneumonia
Myalgia bottom lip feels heavy, jaw feels heavy, bottom lip and jaw numbness Narrative:
This spontaneous report as received from a health care worker referring to six patients of unknown demographics. No relevant medical history was reported. On an unknown date, the patients were vaccinated with PROQUAD (lot number J010597 and expiry date 28-FEB-2015) that was exposed to 41.58F for 446 hours throughout the month of November. No concomitant medications were reported. No adverse effects were reported. The reporter also stated that PROQUAD (lot number J006160 and expiry date 30-JAN-2014) was exposed to 41.58 for 510 hours. The vaccine with lot number J01597 and expiry date 28-FEB-2015 was only administered to six patients. Additional information has been requested